clinical trial · NCT05106153
A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem
Janssen Research & Development, LLC·phase1·completed·n = 127
Healthy Non-dependent, Recreational Sedative UsersAbuse PotentialSuvorexantZolpidemSeltorexantPlacebo
brief summary
The purpose of this study is to evaluate the abuse potential of seltorexant compared to placebo and two active comparators (zolpidem and suvorexant) in non-dependent, recreational sedative users.
started
Dec 17, 2021
primary completion
May 12, 2023
completion
May 12, 2023
last updated
Apr 27, 2025
official title
A Single-Dose, Double-Blind, Placebo-Controlled, Randomized, Crossover Study to Determine the Abuse Potential of Single Oral Dose of Seltorexant Compared To Suvorexant and Zolpidem
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol